We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Drug companies spent over £7.5m on joint working in 2016-17, but 1 in 5 NHS trusts are keeping details secret. This goes against official guidance that urges openness and transparency
Roche and Halozyme are at it again—12 years after their initial collaboration around the latter’s Enhanze drug delivery platform, Roche is licensing it again, this time...